Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance data

MeSH terms

• Anistreplase
• Fibrinolytic Agents / adverse effects*
• Fibrinolytic Agents / therapeutic use
• Follow-Up Studies
• Hospitals, District
• Humans
• Myocardial Infarction / drug therapy*
• Plasminogen / adverse effects*
• Plasminogen / therapeutic use
• Streptokinase / adverse effects*
• Streptokinase / therapeutic use